Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment—An Overview

Author:

Crintea Andreea1,Motofelea Alexandru Cătălin2ORCID,Șovrea Alina Simona3,Constantin Anne-Marie3,Crivii Carmen-Bianca3ORCID,Carpa Rahela4ORCID,Duțu Alina Gabriela1

Affiliation:

1. Department of Molecular Sciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania

2. Department of Internal Medicine, Faculty of Medicine, Victor Babeș University of Medicine and Pharmacy, 300041 Timișoara, Romania

3. Department of Morphological Sciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania

4. Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Institute for Research-Development-Innovation in Applied Natural Sciences, Babeș-Bolyai University, 400084 Cluj-Napoca, Romania

Abstract

Cancer is a leading cause of death worldwide, and the main treatment methods for this condition are surgery, chemotherapy, and radiotherapy. These treatment methods are invasive and can cause severe adverse reactions among organisms, so nanomaterials are increasingly used as structures for anticancer therapies. Dendrimers are a type of nanomaterial with unique properties, and their production can be controlled to obtain compounds with the desired characteristics. These polymeric molecules are used in cancer diagnosis and treatment through the targeted distribution of some pharmacological substances. Dendrimers have the ability to fulfill several objectives in anticancer therapy simultaneously, such as targeting tumor cells so that healthy tissue is not affected, controlling the release of anticancer agents in the tumor microenvironment, and combining anticancer strategies based on the administration of anticancer molecules to potentiate their effect through photothermal therapy or photodynamic therapy. The purpose of this review is to summarize and highlight the possible uses of dendrimers regarding the diagnosis and treatment of oncological conditions.

Funder

Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference213 articles.

1. Bober, Z., Bartusik-Aebisher, D., and Aebisher, D. (2022). Application of Dendrimers in Anticancer Diagnostics and Therapy. Molecules, 27.

2. RGD Engineered Dendrimer Nanotherapeutic as an Emerging Targeted Approach in Cancer Therapy;Sheikh;J. Controll. Release,2021

3. (2023, April 28). What Is Cancer? NIH 2021, Available online: https://www.cancer.gov/about-cancer/understanding/what-is-cancer.

4. (2023, April 28). Cancer. World Health Organization 2022. Available online: https://www.who.int/news-room/fact-sheets/detail/cancer.

5. New Approaches and Procedures for Cancer Treatment: Current Perspectives;Debela;SAGE Open Med.,2021

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3